MAR 12, 2020 6:48 PM PDT

Recent Data Accelerates Coronavirus SARS-CoV2 Drug Discovery

WRITTEN BY: Nouran Amin

Coronavirus (SARS-CoV-2) is a currently a human health crisis. It is not only highly infectious but results severe pneumonia (COVID-19) in some cases. Now, researchers by Prof. Dr. Rolf Hilgenfeld, University of Lübeck, have found an effective approach to studying the coronavirus by using high-intensity X-ray light from the Berlin synchrotron source BESSY II. They analyzed the 3D shape of the main protease (Mpro or also 3CLpro) of SARS-CoV-2. This protein plays a central role for maintaining the virus’s reproductive capability.

Learn more about COVID-19:

Since the world is scrambling to find treatments that work against the SARS-CoV-2, understanding the architecture of the protein is critical to identify specific areas of attack—thus, advancing drug discovery

"For such issues of highest relevance, we can offer fast track access to our instruments," says Dr. Manfred Weiss, who heads the Research Group Macromolecular Crystallography (MX) at HZB.

The high-intensity X-ray light from the BESSY II facility of the Helmholtz-Zentrum Berlin make the images of the 3D architecture of the protein molecules more clear.

“The 3D architecture provides concrete starting points for developing active substances or inhibitors. These drugs could dock specifically to target points of the macromolecule and impede its function,” says Rolf Hilgenfeld is an expert in the field of virology and already developed an inhibitor against the SARS-virus during the 2002/2003 SARS pandemic.

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
APR 14, 2020
Cardiology
APR 14, 2020
Personalized Treatments for Patients with Diabetes and Heart Disease
Often, people who have Type 2 diabetes are at an increased risk for cardiovascular disease. This is because they are usu ...
APR 15, 2020
Chemistry & Physics
APR 15, 2020
Could this drug help people with SAD?
Have you ever been sad in the winter? If so, you’re not alone. Medaka fish feel it too. Seasonal affective disorde ...
APR 16, 2020
Cancer
APR 16, 2020
This drug hopes to prevent cancer relapse
A report published in Nature Communications highlights findings from a study showing that the experimental drug, Qu ...
APR 17, 2020
Chemistry & Physics
APR 17, 2020
Fish Tank Chemicals Aren't COVID-19 Medication, Says FDA
While the medical community is scrambling to find the proper medications for Sars-CoV-02 infection, a significant portio ...
MAY 04, 2020
Immunology
MAY 04, 2020
GeoVax and Sino Bio Collaborate on COVID-19 Vaccine Work
GeoVax Labs, Inc., a biotechnology company developing human vaccines and immunotherapies against infectious diseases and ...
MAY 03, 2020
Drug Discovery & Development
MAY 03, 2020
Hydroxychloroquine: The Controversial Use
COVID-19 was declared a public health threat on January 30th and since then it took the world by a storm with more than ...
Loading Comments...